These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23025324)

  • 1. Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view.
    Helbig G; Kyrcz-Krzemien S
    Leuk Lymphoma; 2013 Apr; 54(4):897-8. PubMed ID: 23025324
    [No Abstract]   [Full Text] [Related]  

  • 2. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
    Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
    [No Abstract]   [Full Text] [Related]  

  • 3. A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.
    Coltro G; Santi R
    Blood; 2023 May; 141(20):2541. PubMed ID: 37200055
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of myeloid neoplasm with FIP1L1-PDGFRA rearrangement without marked peripheral blood eosinophilia.
    Wang J; Zhang Q; Zeng H; Chen B; Ouyang J
    Pharmacogenomics; 2016; 17(2):99-102. PubMed ID: 26666578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?
    Rudzki Z; Giles L; Cross NC; Lumley M
    Br J Haematol; 2012 Mar; 156(5):558. PubMed ID: 22224867
    [No Abstract]   [Full Text] [Related]  

  • 6. The molecular anatomy of the FIP1L1-PDGFRA fusion gene.
    Walz C; Score J; Mix J; Cilloni D; Roche-Lestienne C; Yeh RF; Wiemels JL; Ottaviani E; Erben P; Hochhaus A; Baccarani M; Grimwade D; Preudhomme C; Apperley J; Martinelli G; Saglio G; Cross NC; Reiter A;
    Leukemia; 2009 Feb; 23(2):271-8. PubMed ID: 18987651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia.
    von Bubnoff N; Sandherr M; Schlimok G; Andreesen R; Peschel C; Duyster J
    Leukemia; 2005 Feb; 19(2):286-7. PubMed ID: 15618966
    [No Abstract]   [Full Text] [Related]  

  • 8. Unique association of myeloid neoplasm with eosinophilia and abnormalities of PDGFRA with TTP.
    Chaudhary LN; Bailey NG; Vos JA; Stotler CJ
    W V Med J; 2013; 109(2):6-9. PubMed ID: 23600098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid.
    Miyazawa K; Kakazu N; Ohyashiki K
    Int J Hematol; 2007 Jan; 85(1):5-10. PubMed ID: 17261495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient macular erythema with eosinophilia in a patient carrying the FIP1L1-PDGFRA fusion gene.
    Yahara H; Satoh T; Hashimoto T; Yokozeki H
    Br J Dermatol; 2007 Dec; 157(6):1284-7. PubMed ID: 17916194
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene.
    Sorour Y; Dalley CD; Snowden JA; Cross NC; Reilly JT
    Br J Haematol; 2009 Jul; 146(2):225-7. PubMed ID: 19466970
    [No Abstract]   [Full Text] [Related]  

  • 12. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
    Rathe M; Kristensen TK; Møller MB; Carlsen NL
    Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia.
    Zota V; Miron PM; Woda BA; Raza A; Wang SA
    J Clin Oncol; 2008 Apr; 26(12):2040-1. PubMed ID: 18421057
    [No Abstract]   [Full Text] [Related]  

  • 14. Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up.
    Srinivasan A; Scordino T; Baker A
    J Pediatr Hematol Oncol; 2019 May; 41(4):334-335. PubMed ID: 30807397
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.
    Bikhchandani M; Johnson R; Tuan B; Tefferi A
    Acta Haematol; 2018; 140(2):67-70. PubMed ID: 30184522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
    Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G
    Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
    Metzgeroth G; Walz C; Score J; Siebert R; Schnittger S; Haferlach C; Popp H; Haferlach T; Erben P; Mix J; Müller MC; Beneke H; Müller L; Del Valle F; Aulitzky WE; Wittkowsky G; Schmitz N; Schulte C; Müller-Hermelink K; Hodges E; Whittaker SJ; Diecker F; Döhner H; Schuld P; Hehlmann R; Hochhaus A; Cross NC; Reiter A
    Leukemia; 2007 Jun; 21(6):1183-8. PubMed ID: 17377585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene.
    García-Martínez P; Sitjas D; Llistosella E; Espinet B; Rodríguez-Rivera M; Hernandez-Muñoz M; Gallardo F; Pujol RM
    Acta Derm Venereol; 2017 Jul; 97(7):855-857. PubMed ID: 28374041
    [No Abstract]   [Full Text] [Related]  

  • 19. FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia.
    Tefferi A; Lasho TL; Brockman SR; Elliott MA; Dispenzieri A; Pardanani A
    Haematologica; 2004 Jul; 89(7):871-3. PubMed ID: 15257945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.
    Barraco D; Carobolante F; Candoni A; Simeone E; Piccaluga P; Tabanelli V; Fanin R
    Eur J Haematol; 2014 Jun; 92(6):541-5. PubMed ID: 24460680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.